Edd ca

[CA] If I’m on a paid medical leave of absence, is it necessary to file an EDD claim?

So I recently moved to CA, and because I had out of state wages in the last 18 months before I was just laid off from my CA job, it said I had to file by either fax or phone, with the website saying fax is the quickest.
I was laid off on a Thursday (2/16), I faxed over my application that Saturday (2/18), and I haven't heard anything or gotten anything in the mail since, I have tried to login online and it cannot log me in. I have not received an EDD number in the mail, but I did a workaround I found to find my EDD number, tried using that to log in to manage my claim, and it says "Your information does not match the records in our system" etc, and won't let me log in.
I called about a week or so ago, and after being on hold and transferred for more than an hour and a half, I talked to someone who seemed relatively knowledgeable and told me that when you fax it over, it goes into a cloud where applications are processed from. Unfortunately the call dropped shortly after and I couldn't get an answer onto whether he could see if my application was waiting there for someone to approve it or otherwise, although from the sound of his voice it sounded like he wouldn't be able to confirm that my application was ever actually received or not, and I didn't have the patience to try calling again and waiting for another hour+ to try and get through.
Basically I'm not sure what to do because if it's truly back logged, then I just have to wait, but I have no idea if they even got my application and if its going through the process, and if no one can tell me whether it's there or not, then I have no idea what the next step forward is. Has anyone waited this long to hear back from anything? I haven't received anything in the mail confirming literally anything, I can't certify online or over the phone because I don't have any sort of login info to manage the claim, and I don't want to have to reapply and lose out on the last months worth of back pay because they never got it, so just looking for general information on what to do and if any of this is normal.
Thanks for your help in advance!

Originally boss told us we were shutting down and to put in for unemployment, then went back on it and remained open to get PPP loans two weeks later. Had everyone back in working and still paid us for those two weeks. They had to in order to qualify for ppp loans.
I had already submitted EDD by that time and certified for like 1-2 weeks as not working. (And was later paid for them anyway)
After that for a couple weeks I put in as working full time. CA EDD kept paying even when certifying working full time. No idea why. So I just stopped doing it altogether.
Tried on and off for like a year after to call them and correct the issue. Could never get through.
Issue is still unresolved. BoA account with the money in it has apparently been frozen for “fraud” (tried checking if they ever took the money back). I never touched anything from them and just left it all sitting in the account they made.
My issue is now that the company is super slow. So I’m worried about getting laid off. In that event I would need to put in for unemployment. But it’s my understanding that some kind of investigation or something needs to happen first.
I would rather just settle the issue now instead of later to get this all handled so that everything is smoother if I need to apply for it in the future.
Does anyone have any idea on how to best get this handled? Trying calling them again?

MARCH

March 17:
Amgen is cutting 450 members of its workforce, according to a Reuters report. This is Amgen's second round of layoffs this year; the first, in January, included 300 members of staff.
March 15:
Vaxart, Inc. plans to reorganize its pipeline to prioritize its oral norovirus vaccine program and push back clinical trials for its COVID-19 vaccine. The reorganization includes cutting about 27% of staff in an effort to extend cash flow into 2024.
March 9:
Olema Oncology announced it is shifting its focus to advancing OP-1250, a treatment for ER+/HER2- metastatic breast cancer, into Phase III. The restructuring will include cutting about 25% of its workforce.
March 8:
Neoleukin Therapeutics announced it is reviewing strategic alternatives that could include a sale, merger, divestiture of assets, licensing or other strategic transaction. As a result, the company is cutting 70% of its workforce in the first half of 2023.
March 6:
atai Life Sciences announced it has cut staff by about 30% as part of a in order to extend its cash runway into the first half of 2026. The company stated the decision came after a strategic review of its pipeline in an effort to enhance efficiency and narrow its focus.
Coherus BioSciences announced in its fourth-quarter report that it has cut about 60 full-time and part-time employees from its payroll as part of a restructuring initiative. The company's operating expenses for this year are nearly $100 million lower than those projected in April 2022.
March 2:
MorphoSys AG plans to drop its pre-clinical programs and cut 17% of its workforce to extend its cash runway. The cuts will take place at the company’s Planegg headquarters, and a total of 70 employees will lose their jobs.
March 1:
G1 Therapeutics released its full-year 2022 financial report that stated it has cut its headcount by about 30% to reduce operating expenses in 2023. This comes two weeks after the biotech ended a late-stage study of its lead candidate in colorectal cancer, causing shares to plunge 50%.

FEBRUARY

Feb. 28:
Theravance Biopharma is discontinuing research activities for its JAK inhibitor program in lung inflammation and reducing its headcount by about 17%. The strategic realignment folows a letter from one of Theravance’s largest shareholders, Irenic Capital, urging the company to review its governance structure and reassess its business strategies.
Feb. 24:
ObsEva, a women's health biotech based in Switzerland, is cutting several staff members from its executive team in the U.S. and its board of directors. These cuts include the company's CEO, CMO and several others.
Feb. 22:
Graphite Bio announced it is discontinuing the development of nulabeglogene autogedtemcel (nula-cel), its lead asset. Simultaneously, the Bay Area biotech is launching a corporate restructuring program that will shave off about 50% of its workforce.
Impel Pharmaceuticals is implementing a restructuring initiative that includes cutting staff by 16%. It plans to drop its INP105 treatment for acute agitation and aggression in autism spectrum disorder and focus on developing its Trudhesa nasal spray.
Jounce Therapeutics announced plans to merge its business in an all-stock deal with clinical-stage biotech Redx Pharma. This news came one day after the biotech announced a restructuring plan that included cutting 57% of staff.
Feb. 21:
National Resilience Inc. announced plans to sell a manufacturing site in Marlborough, MA and scale back operations at another in Allston, MA. The decision will result in about 213 job cuts in total.
Aileron Therapeutics announced it plans to drop its its lead candidate, ALRN-6924, after it did not meet the primary or secondary endpoints in a Phase 1b trial studying the candidate in breast cancer patients. As a result, the company will cut its staff from nine employees to three.
Feb. 15:
Grifols announced a comprehensive plan to save money and resources that will result in 2,000 U.S. job cuts. The company stated its goal is to save approximately $428 million USD in 2023.
Feb. 13:
Frequency Therapeutics is cutting 55% of its workforce due to its decision to drop all programs designed to treat Sensorineural Hearing Loss (SNHL). This comes after its candidate, FX-322, did not meet the primary endpoint in SNHL patients in a Phase IIb trial.
Feb. 9:
Eliem Therapeutics is dropping a depression drug candidate that was heading into Phase II and laying off 55% of staff in an attempt to stretch its cash runway into 2027.
Feb. 8:
Aligos Therapeutics announced it has implemented a pipeline reprioritization resulting in a staff reduction of about 25%. The biotech will now prioritize its NASH and COVID-19 assets, including its NASH collaboration with Merck.
Feb. 6:
Thermo Fisher Scientific will cut a total of 230 jobs at several sites in San Diego County, CA. This comes after the pharma reported a significant drop in sales of its COVID-19 tests in 2022.
Magenta Therapeutics is cutting up to 56 positions from its workforce - about 84% of its total staff - according to a filing with the SEC. This comes days after the biotech suspended the development of its clinical programs after a patient's death halted a Phase I/II trial.
Feb. 3:
Eisai Inc. filed a WARN notice with the state of New Jersey that stated it plans to cut 91 jobs. The job cuts will be effective on April 30.
Vyant Bio announced plans to cut its workforce in an attempt to extend its cash runway, though the announcement did not specify how many jobs would be cut. The decision is due to leadership's belief that "its stock price does not reflect the fundamental value of the business."
Medicago, a plant-based COVID-19 vaccine developer, announced it will shut its doors due to a slowdown in the COVID-19 pandemic. This follows the company's November announcement that it planned to lay off 62 employees at a North Carolina manufacturing facility.
Feb. 1:
Evelo Biosciences announced it has implemented cost-saving initiatives that include an unspecified amount of job cuts. In the same announcement, the company also stated its atopic dermatitis candidate, EDP1815, did not meet its primary endpoint in a Phase II trial.

This is from Fierce Biotech as of March 1st.
Sorrento filed a Worker Adjustment and Retraining Notification notice in California, stating that 538 positions could be cut. The company, however, confirmed in a statement to Fierce Biotech that no layoffs have occurred at this time. The WARN notice was issued prior to the securing of a $75 million financing. "Sorrento is currently evaluating its staffing needs in order to continue driving forward its priority trials," the spokesperson said.
Sorrento filed for bankruptcy two weeks ago, with the company revealing $235 million in debt. Sorrento has been in a yearslong legal feud with billionaire drug developer Patrick Soon-Shiong, M.D., and his companies over an alleged scheme to run out the clock on a Sorrento asset bought by Soon-Shiong’s company NantCell. Sorrento was handed a lifeline a week after the bankruptcy notice, however, with a Texas court approving a $75 million loan from JMB Capital Partners.
As part of the financing, Sorrento CEO Henry Ji, Ph.D., indicated that the money would be spent continuing “normal business operations, including the payment of employee wages and benefits and post-petition vendor obligations.”

Demographics

• Gender: Male
• Race/Ethnicity: Asian
• Residence: Indiana
• Income Bracket: 200k+
• Type of School: Public
• Hooks (Recruited Athlete, URM, First-Gen, Geographic, Legacy, etc.): none

Intended Major(s): Computer Science
Academics

• GPA (UW/W): 3.87 UW
• Rank (or percentile): 40/350 (Not accurate, AP/honors participation rate is under 10% at my school)
• # of Honors/AP/IB/Dual Enrollment/etc.: 10 (took every science AP at my school except physics 2)
• Senior Year Course Load: AP Micro, AP Macro, AP Biology, AP English Lit, AP Calc BC

Standardized Testing
List the highest scores earned and all scores that were reported.

• SAT I: 1480 (720RW, 760M)
• ACT: 33 (33M, 33S, 35E, 32R)
• AP/IB: Forgot to upload on CA profile but 4 across the board accept for a 2 in Physics and WHAP

Extracurriculars/Activities
List all extracurricular involvements, including leadership roles, time commitments, major achievements, etc.

1. Science Olympiad State Qualifiers 3 Years in a Row
2. TEAMs Varsity Captain for Team 3 (we had 3 varsity teams)
3. Key Club Designated Community Service Coordinator
4. NHS Member
5. JV Athlete Track

Awards/Honors
List all awards and honors submitted on your application.

1. County Wide Essay Contest Runner Up
2. IASP MLK Essay Contest School Entrant
3. AP Scholar

Letters of Recommendation
AP Calc Teacher (7/10) - We really connected during my Junior year and he took a while to write mine
AP Biology Teacher (5/10) - She gave me a copy for transparency and it was really generic. Just basically said "x student was good for y reasons"
AP Chem TeacheVice Principle (5/10) - Same explanation for AP Biology Teacher
Essays
Personal Essay: Was really unique in my opinion. Was about my fascination with the telephone pole and I connected it back to my connection, or lack thereof, with my family
Decisions (indicate ED/EA/REA/SCEA/RD)
ED: Cornell CS (Rejected)
EA: Purdue (Accepted!!!!!)
UIUC (Rejected)
IU Bloomington (Accepted + Scholarship)
Comments
How the turntables have tide turned. In all seriousness, I am super happy with Purdue. Outside of being ranked nationally in the field, I have a sort of odd connection with the campus. They used to host some of my middle school band concerts and were where a majority of my Science Olympiad competitions took place. It was my number 1 choice from the get-go (I ED'd to Cornell just for fun) and I am super proud to call myself a future Boilermaker :D

F(26) CA part-time, my employer just give me one day(3-4hrs) a week and I kinda want to quit because the environment is not good anymore. i am a job seeker basically, but my dad helps me out with food and stuff.i have enough savings in my account, but it's for emergency, and I still have to pay for my car monthly(under my dad's name)
is my savings account gonna affect my application?I just applied for foodstamps and get denied.i want to try edd,if anything.
ill take all advice in the comments section and thank you.
​

Hi there,
I gave birth in July 2022 and took disability as i had a c-section.
I did not take paid family leave.
I have not received a 1099 from CA. My husband who did take Paid FAmily LEave did receive his 1099.
Becuase I took disability only (paid by EDD) will i not get a 1099?
​
Am I OK to file my taxes or do i need to take action?

Flight Instructors paid as Independent Contractors (1099)
Flight instructors at some of the largest schools across the United States are being paid as Independent Contractors (1099) instead of Employees (W2). This is illegal and you are being underpaid for your services. In most cases, flight instructors do not meet the qualifications of an Independent Contractor, thus your employer must pay Social Security and Medicare taxes.
​
What am I Owed?
At minimum, you are owed the employer portion of payroll taxes, about 7.5% of gross wages. However, in many cases the employer can be held liable for employee portions of payroll taxes, unemployment tax, workers comp, and more. These can be up to about 15% of gross wages. Additionally, you may be owed for uncompensated work time (required meetings/training or briefing/ground time with students) and overtime pay. For a typical flight instructor, these may add up to $5,000 or more during your time with a school.
​
Why am I an Employee?

1. Integral Part of Business - Flight instructors make up the majority of a Flight School’s payroll and critical to daily functions. Flight School’s primary service is one-on-one flight instruction, completed by misclassified independent contractors.
2. Permanence of Relationship - Flight instructors generally work for the company for 1-2 years in order to build the hours and experience required to move on to the next step in their career. This is not a short term or seasonal position.
3. Worker’s Investment in Facilities/Equipment - All aircraft, facilities, maintenance, and other related supplies typically furnished by the flight school.
4. Control by the Principal - Flight schools often exercise considerable control over flight instructor schedules by laying out strict timelines in which they must complete student training.
5. Worker’s Opportunity for Profit/Loss - Worker only earn wages and have no opportunity for profit or loss.
6. Independent Advertising of Services - Flight School instructors often work exclusively for a single flight school with no independent advertising.

​
How do I get Compensation?
The best way to start is to contact your state workforce agency and let them know your employer has misclassified you as an Independent Contractor (1099) instead of an Employee (W2). They can help you file the appropriate paperwork and obtain compensation.
Contact Local Workforce Agency:
https://www.naswa.org/membership/workforce-agencies

• Texas: https://www.twc.texas.gov/businesses/classifying-employees-independent-contractors
• California: https://edd.ca.gov/en/Payroll_Taxes/Independent_Contractor_Reporting
• Florida: https://floridarevenue.com/taxes/taxesfees/Pages/rt_employee.aspx

​
File with the IRS:
https://www.irs.gov/pub/irs-pdf/fss8.pdf
https://www.irs.gov/pub/irs-pdf/f8919.pdf
https://www.irs.gov/businesses/small-businesses-self-employed/independent-contractor-self-employed-or-employee

The latest pair of announcements is indicative of an unrelenting cratering of the biotech workforce marked by nearly 40 companies revealing head count reductions so far this year. Through the first two months of 2023, 38 drug developers laid off staff, according to the Fierce Biotech Layoff Tracker, nearly triple the number over the same period in 2022.
For G1 Therapeutics, the reasons for the layoffs fit an all-too-familiar pattern for biotechs. That is to say, the company is shrinking by 30% to save money for trial readouts, although it noted that the sales team behind its FDA-approved myeloprotection therapy Cosela remains intact.
The cancer-focused company says that the reduction in staff combined with other cost-saving measures could lower costs this year by up to 30% compared to 2022. The belt-tightening should also allow G1 to operate through all upcoming readouts of Cosela in other indications.

As of the end of the year, G1 reported having just over $140 million on hand, down from $221 million at the end of 2021. Total Cosela revenue for the year eclipsed $51 million, up nearly $20 million from 2021.

Sorrento, meanwhile, filed a Worker Adjustment and Retraining Notification notice in California, stating that 538 positions could be cut. The company, however, confirmed in a statement to Fierce Biotech that no layoffs have occurred at this time. The WARN notice was issued prior to the securing of a $75 million financing. "Sorrento is currently evaluating its staffing needs in order to continue driving forward its priority trials," the spokesperson said.
Sorrento filed for bankruptcy two weeks ago, with the company revealing $235 million in debt. Sorrento has been in a yearslong legal feud with billionaire drug developer Patrick Soon-Shiong, M.D., and his companies over an alleged scheme to run out the clock on a Sorrento asset bought by Soon-Shiong’s company NantCell. Sorrento was handed a lifeline a week after the bankruptcy notice, however, with a Texas court approving a $75 million loan from JMB Capital Partners.
As part of the financing, Sorrento CEO Henry Ji, Ph.D., indicated that the money would be spent continuing “normal business operations, including the payment of employee wages and benefits and post-petition vendor obligations.”
Warning, the article begins with a header that is advertising. Scroll down to read the article.
Link to Article

Can someone validate the closure notice list on attached link or is it BS??
https://edd.ca.gov/siteassets/files/jobs_and_training/warn/warn_report.xlsx

I am a mail in filer in CA. I mailed mine in around early Feb and just got edd for my state refund as 3/7 and federal as 3/10. That's pretty damn efficient, less than 4 weeks!

Questions:

1. If my BOA EDD debit card has no balance at all, do I have to still keep the EDD debit card?
2. Does CA EDD issue a new EDD debit card to me, or re-use the same (prior) EDD debit card, if a new unemployment benefit is approved in the future?

TIA!